Effectiveness of intravenous administration of fe-gluconate-na complex to maintain adequate body iron stores in hemodialysis patients

American Journal of Nephrology

Volumn 16, Issue 4, 1996, Pages 268-272

  Navarro, Juan F ^a   Teruel, José L ^a   Liaño, Fernando ^a   Marcén, Roberto ^a   Ortuño, Joaquín ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Adequate body iron stores; Anemia; Fe gluconate Na complex; Ferropenia; Hemodialysis patients

Indexed keywords

FERRIC GLUCONATE; HEMOGLOBIN; IRON LECITHIN COMPLEX; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON STORAGE; MAINTENANCE THERAPY; MALE; MENSTRUATION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0029978129     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169008     Document Type: Article

References (22)

1. Longneckcr RE, Goffinct JA, Hendlcr ED: Blood loss from maintenance hemodialysis. Trans Am Soc Artif Intern Organs 1974;242: 135-141.
2. MacDougall JC, Hutton RD, Cavill I, Coles GA, Williams JD: Treating renal anemia with recombinant human erythropoietin: Practical guidelines and a clinical algorithm. Br Med J 1990:300:655-659.
3. Gokal R, Millard PR, Weathcrall DJ, Callender ST, Ledingham JG, Oliver DO: Iron metabolism in hemodialysis patients: A study of the mesurcment of iron therapy and overload. Q J Med 1979;48:369-391.
4. Ali M, Faycmi O, Rigolosi R, Frascino J, Marsden T, Malcolm D: Hemosiderosis in he-modialvsis patients. JAMA 1980:244:343-345.
5. Murray JA, Slater DN, Parson MA, et al: Splenic siderosis and parenteral iron in maintenance hemodialysis patients. J Clin Pathol 1984:37:59-64.
6. Thea A, Canarcse C, Mangiarott G, et al: Three-year follow-up after withdrawal of iron therapy in uremic patients on regular dialytic treatment. Res Clin Lab 1985:5:142-146.
7. Van Wyck D, Stivclman J, Ruiz J, Kirlin L, Katz M, Ogden D: Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 1989;35:712-716.
8. Anastassiades E, Howarth D, Howarth J, et al: Monitoring of iron requirements in renal patients on erythropoietin. Nephrol Dial Transplant 1993:8:846-853.
9. Cook JD, Skiknc BS, Lynch SR, Reusser ME: Estimates of iron sufficiency in the US population. Blood 1986;68:726-731.
10. Cook JD: Clinical evaluation of iron deficiency. Semin Hematol 1982:19:6-18.
11. Moreb J, Poportzer MM, Friedlander MM, Konijn AM, Hcrshko E: Evaluation of iron status in patients on chronic hemodialysis: Relative usefulness of bone marrow saturation, mean corpuscular volume and red cell protoporphyrin. Nephron 1983;35:196-200.
12. Finch C, Huebers H: Perspectives in iron metabolism. N Engl J Med 1982:306:1520-1528.
13. Guyatt GH, Patterson C, Ali M, et al; Diagnosis of iron deficiency anemia in the elderly. Am JMed 1990:88:205-209.
14. Quereda C, Escribano L, Vila T, Mareen R, Garcia Laraña J, Estébanez C, et al: Valor dc la determinación de ferritina sérica para el diagnóstico de ferropenia en enfermos urcmicos. Sangre 1981;26:447-455.
15. Morris K, Watson S, Reid M, Hamilton P, Coulthard M: Assessing iron status in children with chronic renal failure on erythropoietin: Which mesurements should we use. Pcdiatr Nephrol 1994:8:51-56.
16. Jacob R, Sandtead H, Kleray L, Johnson L: Utility of serum ferritin as a measure of iron deficiency in normal males undergoing repetitive phlebotomy. Blood 1980:56:786-791.
17. Thea A, Canavese C, Mangiarotti J, et al: Three-year follow-up after withdrawal of iron therapy in uremic patients on regular dialytic treatment. Res Clin Lab 1986:16:517-522.
18. MacDougall JC, Hutton RD, Cavill I, Coles GA, Williams J: Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 1989:299: 157-158.
19. Allegra V, Mengozzi G, Vasile A: I ron deficiency in maintenance hemodialysis patients: Assessment of diagnosis criteria and of three different iron treatments. Nephron 1991:57:175-182.
20. Pascual J, Teruel J, Liaho F, Sureda A, Ortuno J: Intravenous Fc-gluconate-Na for iron-deficient patients on hemodialysis. Nephron 1992: 60:121.
21. Hamstra RD, Block NH, Schocket AL: Intravenous iron dextran in clinical medicine. JAMA 1980:243:1726-1731.
22. Pascual J. Teruel JL, Liano F, Sureda A, Ortuno J: Serious adverse reactions after intravenous ferric gluconate. Nephrol Dial Transplant 1992;7:271-272.